These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34508956)
1. Multifunctional carbon monoxide nanogenerator as immunogenic cell death drugs with enhanced antitumor immunity and antimetastatic effect. Xiao X; Liang S; Zhao Y; Pang M; Ma P; Cheng Z; Lin J Biomaterials; 2021 Oct; 277():121120. PubMed ID: 34508956 [TBL] [Abstract][Full Text] [Related]
2. Focused acoustic vortex-mediated sonochemotherapy for the amplification of immunogenic cell death combined with checkpoint blockade to potentiate cancer immunotherapy. Ya Z; Guo S; Li Y; Zhu M; Zhang L; Zong Y; Wan M Biomaterials; 2023 Oct; 301():122278. PubMed ID: 37598439 [TBL] [Abstract][Full Text] [Related]
3. Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade. Zhang B; Li N; Gao J; Zhao Y; Jiang J; Xie S; Zhang C; Zhang Q; Liu L; Wang Z; Ji D; Wu L; Ren R J Exp Clin Cancer Res; 2024 Feb; 43(1):51. PubMed ID: 38373953 [TBL] [Abstract][Full Text] [Related]
4. Combination Cancer Immunotherapy of Nanoparticle-Based Immunogenic Cell Death Inducers and Immune Checkpoint Inhibitors. Qi J; Jin F; Xu X; Du Y Int J Nanomedicine; 2021; 16():1435-1456. PubMed ID: 33654395 [TBL] [Abstract][Full Text] [Related]
6. Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy. Xu W; Liu W; Yang J; Lu J; Zhang H; Ye D Immunol Rev; 2024 Jan; 321(1):181-198. PubMed ID: 37403660 [TBL] [Abstract][Full Text] [Related]
7. Low Dose Soft X-Ray Remotely Triggered Lanthanide Nanovaccine for Deep Tissue CO Gas Release and Activation of Systemic Anti-Tumor Immunoresponse. Li Y; Jiang M; Deng Z; Zeng S; Hao J Adv Sci (Weinh); 2021 Jun; 8(12):e2004391. PubMed ID: 34165903 [TBL] [Abstract][Full Text] [Related]
8. Phenolic immunogenic cell death nanoinducer for sensitizing tumor to PD-1 checkpoint blockade immunotherapy. Xie L; Wang G; Sang W; Li J; Zhang Z; Li W; Yan J; Zhao Q; Dai Y Biomaterials; 2021 Feb; 269():120638. PubMed ID: 33421711 [TBL] [Abstract][Full Text] [Related]
9. Cancer immunogenic cell death via photo-pyroptosis with light-sensitive Indoleamine 2,3-dioxygenase inhibitor conjugate. Lu Y; Xu F; Wang Y; Shi C; Sha Y; He G; Yao Q; Shao K; Sun W; Du J; Fan J; Peng X Biomaterials; 2021 Nov; 278():121167. PubMed ID: 34624752 [TBL] [Abstract][Full Text] [Related]
10. Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor. Wei X; Song M; Jiang G; Liang M; Chen C; Yang Z; Zou L Theranostics; 2022; 12(12):5272-5298. PubMed ID: 35910806 [TBL] [Abstract][Full Text] [Related]
11. Nanomicelle protects the immune activation effects of Paclitaxel and sensitizes tumors to anti-PD-1 Immunotherapy. Yang Q; Shi G; Chen X; Lin Y; Cheng L; Jiang Q; Yan X; Jiang M; Li Y; Zhang H; Wang H; Wang Y; Wang Q; Zhang Y; Liu Y; Su X; Dai L; Tang M; Li J; Zhang L; Qian Z; Yu D; Deng H Theranostics; 2020; 10(18):8382-8399. PubMed ID: 32724476 [TBL] [Abstract][Full Text] [Related]
12. Multifunctional Nano-Biomaterials for Cancer Therapy via Inducing Enhanced Immunogenic Cell Death. Chen Q; Li C; Wang Q Small Methods; 2023 May; 7(5):e2201457. PubMed ID: 36703555 [TBL] [Abstract][Full Text] [Related]
13. Tumor microenvironment-triggered Ding B; Zheng P; Li D; Wang M; Jiang F; Wang Z; Ma P; Lin J Nanoscale; 2021 Jun; 13(24):10906-10915. PubMed ID: 34128036 [TBL] [Abstract][Full Text] [Related]
14. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer. Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591 [TBL] [Abstract][Full Text] [Related]
15. Nitric Oxide Induces Immunogenic Cell Death and Potentiates Cancer Immunotherapy. Jiang W; Dong W; Li M; Guo Z; Wang Q; Liu Y; Bi Y; Zhou H; Wang Y ACS Nano; 2022 Mar; 16(3):3881-3894. PubMed ID: 35238549 [TBL] [Abstract][Full Text] [Related]
16. Improvement strategy for immune checkpoint blockade: A focus on the combination with immunogenic cell death inducers. Shi F; Huang X; Hong Z; Lu N; Huang X; Liu L; Liang T; Bai X Cancer Lett; 2023 May; 562():216167. PubMed ID: 37031916 [TBL] [Abstract][Full Text] [Related]
17. Upregulated Immunogenic Cell-Death-Associated Gene Signature Predicts Reduced Responsiveness to Immune-Checkpoint-Blockade Therapy and Poor Prognosis in High-Grade Gliomas. Tang X; Guo D; Yang X; Chen R; Jiang Q; Zeng Z; Li Y; Li Z Cells; 2022 Nov; 11(22):. PubMed ID: 36429083 [No Abstract] [Full Text] [Related]
18. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy. Zhou L; Zhang P; Wang H; Wang D; Li Y Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102 [TBL] [Abstract][Full Text] [Related]
19. Reinforcing the immunogenic cell death to enhance cancer immunotherapy efficacy. Yu S; Xiao H; Ma L; Zhang J; Zhang J Biochim Biophys Acta Rev Cancer; 2023 Sep; 1878(5):188946. PubMed ID: 37385565 [TBL] [Abstract][Full Text] [Related]
20. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death. Banstola A; Poudel K; Kim JO; Jeong JH; Yook S J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]